Skip to main content
Caplight Logo









Signify Bio

Signify Bio

Private
Dallas, TexasHealthcare & Life Scienceshttps://signifybio.com/

Last Round

Seed

Jun 5, 2025

Total Funding Raised

$15M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Signify Bio is a biotechnology company that develops in situ protein therapeutics by leveraging the human body’s natural ability to produce proteins.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

mRNA therapeuticsin situ protein productionlipid nanoparticleLNPdrug delivery systemcomputational protein designbiofactoryprecision medicinebiotech platformin vivo drug deliverygenetic medicinedrug discoveryprotein engineeringnucleic acid therapeuticsin silico drug design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Signify Bio Comparables

Compare Signify Bio with similar companies based on industry and business-model similarity.

Signify Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Strand Therapeutics
77%
ReCode Therapeutics
74%
Avenue Biosciences
73%

Signify Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 5, 2025

Key People

Founding team and executive leadership

RA Session

Co-Founder, CEO President

Founding Team

Signify Bio Investors

Notable investors and investment history

Signify Bio investors
InvestorRounds
BrightEdgeSeed
Danaher VenturesSeed
BrightEdgeSeed
Actium GroupSeed
Bill & Melinda Gates FoundationSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 7, 2026

    Open roles increased to 7, 58% of headcount.

  • Aug 31, 2026

    Open roles increased to 4, 4x the trailing average.

Signify Bio Filings

Explore SEC and related filing metadata, where available.

Signify Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Signify Bio's valuation, stock price, and market status.

Is Signify Bio a public or private company?

Signify Bio is a private company.

What is the current stock price of Signify Bio?

Signify Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Signify Bio worth (valuation)?

Valuation information for Signify Bio is not publicly available.

Can I buy Signify Bio stock?

Signify Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Signify Bio's last funding round?

Signify Bio's most recent funding round was Seed on June 5, 2025.

Who are the main investors in Signify Bio?

Key investors in Signify Bio include Actium Group.

Will Signify Bio IPO soon?

No public IPO plans have been announced for Signify Bio.

How can I track Signify Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Signify Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDallas, Texas
Employee Range11
Year Founded2024
Last FundingJun 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?